Terms: = Leukemia AND HIP1, ILWEQ, 3092, ENSG00000127946 AND Treatment
3 results:
1. [Impact of duration of antibiotic therapy on the prognosis of patients with acute myeloid leukemia who had Gram-negative bloodstream infection in consolidation chemotherapy].
Gu RX; Wei H; Wang Y; Liu BC; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Gong XY; Li Y; Qiu SW; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):471-475. PubMed ID: 30032562
[No Abstract] [Full Text] [Related]
2. Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.
Philips ST; Hildenbrand ZL; Oravecz-Wilson KI; Foley SB; Mgbemena VE; Ross TS
Oncogene; 2014 Nov; 33(46):5379-90. PubMed ID: 24240679
[TBL] [Abstract] [Full Text] [Related]
3. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a leukemia Intergroup study.
Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A
Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816
[TBL] [Abstract] [Full Text] [Related]
